Monitor and Evaluate 1. Uncontrolled painful diabetic neuropathy ■ Improved symptoms based on pain levels, improved function and quality of life, improved sleep quality. ■ Signs and symptoms of side...

Monitor and Evaluate

1. Uncontrolled painful diabetic neuropathy

■ Improved symptoms based on pain levels, improved function and quality of life, improved sleep quality.

■ Signs and symptoms of side effects upon initiation and slow titration of gabapentin: daytime sedation, confusion.

■ Improved haemoglobin A1C every 3 months following adjustments after follow-up with PCP for diabetes mellitus (DM) management, attendance of diabetes self-management skills class.

2. Constipation

■ Bristol stool chart and signs and symptoms of constipation (signs of straining, incomplete evacuation).

■ Frequency of use of polyethylene glycol 3350 to determine whether this should be scheduled.

3. Hypertension/dyslipidaemia

■ Continued control with current regimen, no reports of adverse drug reaction (ADRs).